Literature DB >> 7769674

Influence of transmembrane domains on the fusogenic abilities of human and murine leukemia retrovirus envelopes.

C Denesvre1, P Sonigo, A Corbin, H Ellerbrok, M Sitbon.   

Abstract

The envelopes of two highly divergent oncoviruses, human T-cell leukemia virus type 1 (HTLV-1) and Friend murine leukemia virus (F-MuLV), have distinct patterns of cellular receptor recognition, fusion, and syncytium formation. To analyze the influence of the transmembrane envelope subunit (TM) on fusogenic properties, we substituted either the entire TM or distinct domains from F-MuLV for the corresponding domains in the HTLV-1 envelope. Parental, chimeric, and truncated envelopes cloned into a eukaryotic expression vector were monitored for fusogenic potential in human, rat, and murine indicator cell lines by using a quantitative assay. This highly sensitive assay allowed us to assess the fusogenic properties and syncytium-forming abilities of the HTLV-1 envelope in murine NIH 3T3 cells. All chimeric envelopes containing extracellular sequences of the F-MuLV TM were blocked in their maturation process. Although deletions of the HTLV-1 cytoplasmic domain, alone and in combination with the membrane-spanning domain, did not prevent envelope cell surface expression, they impaired and suppressed fusogenic properties, respectively. In contrast, envelopes carrying substitutions of membrane-spanning and cytoplasmic domains were highly fusogenic. Our results indicate that these two domains in F-MuLV and HTLV-1 constitute structural entities with similar fusogenic properties. However, in the absence of a cytoplasmic domain, the F-MuLV membrane-spanning domain appeared to confer weaker fusogenic properties than the HTLV-1 membrane-spanning domain.

Entities:  

Mesh:

Year:  1995        PMID: 7769674      PMCID: PMC189151          DOI: 10.1128/JVI.69.7.4149-4157.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion.

Authors:  E Helseth; U Olshevsky; D Gabuzda; B Ardman; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

Review 2.  Retrovirus envelope glycoproteins.

Authors:  E Hunter; R Swanstrom
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions.

Authors:  L G Perez; G L Davis; E Hunter
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  A general model for the transmembrane proteins of HIV and other retroviruses.

Authors:  W R Gallaher; J M Ball; R F Garry; M C Griffin; R C Montelaro
Journal:  AIDS Res Hum Retroviruses       Date:  1989-08       Impact factor: 2.205

5.  Envelope gene sequence of HTLV-1 isolate MT-2 and its comparison with other HTLV-1 isolates.

Authors:  G S Gray; M White; T Bartman; D Mann
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

6.  Small GTP-binding protein associated with Golgi cisternae.

Authors:  B Goud; A Zahraoui; A Tavitian; J Saraste
Journal:  Nature       Date:  1990-06-07       Impact factor: 49.962

7.  Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.

Authors:  O Danos; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  HTLV-I p27rex regulates gag and env protein expression.

Authors:  M C Dokhelar; H Pickford; J Sodroski; W A Haseltine
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

9.  Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.

Authors:  T J Palker; M E Tanner; R M Scearce; R D Streilein; M E Clark; B F Haynes
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

10.  Human T cell leukemia viruses use a receptor determined by human chromosome 17.

Authors:  M A Sommerfelt; B P Williams; P R Clapham; E Solomon; P N Goodfellow; R A Weiss
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

View more
  19 in total

1.  Role of the cytoplasmic tail of ecotropic moloney murine leukemia virus Env protein in fusion pore formation.

Authors:  G B Melikyan; R M Markosyan; S A Brener; Y Rozenberg; F S Cohen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.

Authors:  A R Rosenberg; L Delamarre; C Pique; D Pham; M C Dokhélar
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins.

Authors:  O Pleskoff; C Tréboute; M Alizon
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

4.  A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes.

Authors:  D Lavillette; M Maurice; C Roche; S J Russell; M Sitbon; F L Cosset
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

5.  Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice.

Authors:  Saifur Rahman; Sharrón L Manuel; Zafar K Khan; Brian Wigdahl; Edward Acheampong; Frederic Tangy; Pooja Jain
Journal:  J Immunol       Date:  2010-04-09       Impact factor: 5.422

6.  Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.

Authors:  Dimitri Lavillette; Alessia Ruggieri; Bertrand Boson; Marielle Maurice; François-Loïc Cosset
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide.

Authors:  M Li; C Yang; R W Compans
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide.

Authors:  C Yang; R W Compans
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  A chimeric human T-cell lymphotropic virus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells.

Authors:  Frédéric Delebecque; Karin Pramberger; Marie-Christine Prévost; Michel Brahic; Frédéric Tangy
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Dissociation of the CD4 and CXCR4 binding properties of human immunodeficiency virus type 1 gp120 by deletion of the first putative alpha-helical conserved structure.

Authors:  D Missé; M Cerutti; I Schmidt; A Jansen; G Devauchelle; F Jansen; F Veas
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.